Quantum Genomics S.A.
QNNTF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.02 | 0.01 | -0.24 | 0.27 |
| FCF Yield | 0.00% | 0.00% | -18.44% | -15.99% |
| EV / EBITDA | -6.17 | -0.81 | -3.43 | -4.98 |
| Quality | ||||
| ROIC | -806.14% | -98.42% | -409.88% | -126.34% |
| Gross Margin | -11,453,070.00% | -7,169.57% | -1,073.02% | -296.66% |
| Cash Conversion Ratio | – | – | 0.81 | 0.98 |
| Growth | ||||
| Revenue 3-Year CAGR | -98.42% | -84.94% | 11.20% | 55.35% |
| Free Cash Flow Growth | 0.00% | 100.00% | -18.47% | -37.55% |
| Safety | ||||
| Net Debt / EBITDA | -1.59 | 0.29 | 0.25 | 0.52 |
| Interest Coverage | -131.89 | -146.59 | -1,702.31 | -1,280.37 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | -2.29 | 0.00 |
| Cash Conversion Cycle | -46.34 | 2,128.35 | 1,514.46 | -77.23 |